Arbutus Biopharma

ABUS

6.40

-0.25

-3.8%

After Hours:

6.25

-0.15

-2.3%

Please Login or Register

Login|Register FREE

Stock Price
Open: 6.55
Prev. Close: 6.65
Low/Hi: 6.25 - 6.60
52-Week: 2.35 - 8.25
Volumes
Equity: 170,210
90-Day Avg: 256,318
Option: 215
90-Day Avg: 131
Volatility
Todays Stock Vol: 51.9
20-Day (HV): 88.4
52-Week (HV): 64.2
30-Day IV: 88.1 -2.3
IV Pct Rank: 92% Elevated
Fundamental
Div. Yield: 0.0%
Earnings: 3-Nov (Est.)
P/E Ratio:
Market Cap: 369.3 M
Stock Type: Common
Sector: Healthcare
Industry: Biotechnology
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

ABUS Balance Sheet

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Jun-2017 31-Mar-2017 31-Dec-2016 30-Sep-2016
Cash and Cash Equivalents 24,212 29,851 23,413 26,630
Short Term Investments 78,797 80,528 107,146 123,052
Investments - - - -
Accounts Receivable 1,330 8,314 694 671
Inventory 0 0 0 0
Loans - - - -
Prepaid Expenses 1,583 1,575 1,311 1,459
Net Property Plant and Equipment 12,743 11,462 6,945 4,086
Other Current Assets 0 0 0 0
Current Assets 105,922 120,268 132,564 151,812
Goodwill and Intangibles 123,809 123,809 123,809 358,832
Long Term Investments 0 0 0 0
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 255,075 268,140 275,919 514,730
Short Term Debt 0 0 0 0
Other Non-Current Assets 12,601 12,601 12,601 0
Accounts Payable 8,274 7,428 9,910 7,132
Accrued Liabilities and Other Payables 0 0 0 0
Long Term Debt 12,001 12,001 12,001 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 79,289 79,042 72,914 98,105
Other Current Liabilities 3,607 3,443 675 1,260
Accumulated Other Comprehensive Income -49,782 -49,782 -49,782 -49,782
Preferred Stock 0 0 0 0
Current Liabilities 11,881 10,871 10,585 8,392
Common Stock 873,841 870,847 867,393 864,375
Other Non-Current Liabilities 55,407 56,170 50,328 89,713
Additional Paid-In Capital 39,758 37,809 36,543 34,486
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -688,031 -669,776 -651,149 -432,454
Total Equity 175,786 189,098 203,005 416,625
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014 31-Dec-2013
Cash and Cash Equivalents 23,413 166,779 72,187 68,717
Short Term Investments 107,146 14,525 39,974 0
Investments - - - -
Accounts Receivable 694 1,382 2,527 369
Inventory 0 0 0 0
Loans - - - -
Prepaid Expenses 1,311 1,196 1,730 1,084
Net Property Plant and Equipment 6,945 3,183 1,760 1,373
Other Current Assets 0 0 0 173
Current Assets 132,564 183,882 116,418 70,343
Goodwill and Intangibles 123,809 515,156 0 0
Long Term Investments 0 10,070 0 0
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 275,919 712,291 118,178 71,716
Short Term Debt 0 0 0 0
Other Non-Current Assets 12,601 0 0 0
Accounts Payable 9,910 8,827 9,328 3,680
Accrued Liabilities and Other Payables 0 0 0 0
Long Term Debt 12,001 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 72,914 164,612 30,143 12,522
Other Current Liabilities 675 1,751 10,878 8,842
Accumulated Other Comprehensive Income -49,782 -49,782 -22,313 -15,825
Preferred Stock 0 0 0 0
Current Liabilities 10,585 10,578 20,206 12,522
Common Stock 867,393 834,240 290,004 216,702
Other Non-Current Liabilities 50,328 154,034 9,937 0
Additional Paid-In Capital 36,543 30,206 26,208 25,343
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -651,149 -266,985 -205,864 -167,027
Total Equity 203,005 547,679 88,035 59,193